Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine

Bioorganic and Medicinal Chemistry Letters

Volumn 22, Issue 21, 2012, Pages 6642-6646

  Clouser, Christine L ^a,b   Chauhan, Jay ^c   Bess, Matthew A ^a,b   Oploo, Jessica L Van ^a,b,c   Zhou, Ding ^c   Dimick Gray, Sarah ^c   Mansky, Louis M ^a,b,c   Patterson, Steven E ^a,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Antiviral; Decitabine; HIV 1; Mutagenesis; Resveratrol

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; PHENOL DERIVATIVE; PICEATANNOL; RESVERATROL; RESVERATROL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; DRUG SYNTHESIS; GENE MUTATION; GROWTH INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS STRAIN;

ANTI-HIV AGENTS; AZACITIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HIV-1; HUMANS; MOLECULAR STRUCTURE; STILBENES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84867583318     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2012.08.108     Document Type: Article

References (26)

1. (UNAIDS), J. U. N. P. o. H. A.; WHO, 2010; Vol. 2010.
2. S.M. Hammer, J.J.J. Eron, P. Reiss, R.T. Schooley, M.A. Thompson, S. Walmsley, P. Cahn, M.A. Fischl, J.M. Gatell, M.S. Hirsch, D.M. Jacobsen, J.S. Montaner, D.D. Richman, P.G. Yeni, and P.A. Volberding JAMA 300 2008 555
3. J.M. Coffin Science 267 1995 483
4. J.W. Drake, and J.J. Holland Proc. Nat. Acad. Sci. U.S.A. 96 1999 13910
5. S. Crotty, and R. Andino Microbes Infect. 4 2002 1301
6. J.D. Graci, D.A. Harki, V.S. Korneeva, J.P. Edathil, K. Too, D. Franco, E.D. Smidansky, A.V. Paul, B.R. Peterson, D.M. Brown, D. Loakes, and C.E. Cameron J. Virol. 81 2007 11256
7. L.A. Loeb, J.M. Essigmann, F. Kazazi, J. Zhang, K.D. Rose, and J.I. Mullins Proc. Nat. Acad. Sci. U.S.A. 96 1999 1492
8. C.M. Ruiz-Jarabo, C. Ly, E. Domingo, and J.C. de la Torre Virology 308 2003 37
9. R.A. Smith, L.A. Loeb, and B.D. Preston Virus Res. 107 2005 215
10. M.J. Dapp, C.L. Clouser, S. Patterson, and L.M. Mansky J. Virol. 83 2009 11950
11. W.E. Severson, C.S. Schmaljohn, A. Javadian, and C.B. Jonsson J. Virol. 77 2003 481
12. A.M. Contreras, Y. Hiasa, W. He, A. Terella, E.V. Schmidt, and R.T. Chung J. Virol. 76 2002 8505
13. J.M. Cuevas, F. Gonzalez-Candelas, A. Moya, and R. Sanjuan J. Virol. 83 2009 5760
14. G. Lutchman, S. Danehower, B.C. Song, T.J. Liang, J.H. Hoofnagle, M. Thomson, and M.G. Ghany Gastroenterology 132 2007 1757
15. C.L. Clouser, S.E. Patterson, and L.M. Mansky J. Virol. 84 2010 9301
16. L.R. Sumpter, M.S. Inayat, E.E. Yost, W. Duvall, E. Hagan, C.N. Mayhew, H.L. Elford, and V.S. Gallicchio Antiviral Res. 62 2004 111
17. F. Lori, A. Malykh, A. Cara, D. Sun, J.N. Weinstein, J. Lisziewicz, and R.C. Gallo Science 266 1994 801
18. S. Davidoff, R.D. Shah, and T. Arunabh Respir. Med. 100 2006 760
19. N. Gupta, I. Ahmed, H. Steinberg, D. Patel, S. Nissel-Horowitz, and B. Mehrotra Am. J. Clin. Oncol. 25 2002 96
20. J. Lisziewicz, A. Foli, M. Wainberg, and F. Lori Drug Saf. 26 2003 605
21. A. Heredia, C. Davis, and R. Redfield J. Acquir. Immune Defic. Syndr. 25 2000 246
22. L.X. Wang, A. Heredia, H. Song, Z. Zhang, B. Yu, C. Davis, and R. Redfield J. Pharm. Sci. 93 2004 2448
23. H.S. Zhang, Y. Zhou, M.R. Wu, H.S. Zhou, and F. Xu Life Sci. 85 2009 484
24. H.S. Zhang, and M.R. Wu Virus Res. 146 2009 51
25. M. Fontecave, M. Lepoivre, E. Elleingand, C. Gerez, and O. Guittet FEBS Lett. 421 1998 277
26. M.N. Prichard, and C. Shipman Jr. Antiviral Res. 14 1990 181